Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls.
The acute effects of diazepam on plasma GABA were determined in 18 patients with panic disorder, 13 patients with generalized anxiety disorder and 20 healthy controls. All subjects were benzodiazepine-naive. Four logarithmically increasing doses of diazepam/placebo were administered intravenously at 15-min intervals on 2 separate days. Plasma GABA was measured at baseline and 3 min after the highest dose of diazepam/placebo. There was an overall decrease in plasma GABA that was significantly greater following diazepam compared with placebo, but no group differences in response. In a separate group of 18 panic disorder patients receiving chronic benzodiazepine treatment with alprazolam, the same diazepam infusion procedure (no placebo day) produced decreases in plasma GABA similar to those seen in the untreated panic disorder patients. The clinical and physiologic implications of these findings are discussed.
Roy-Byrne
P P
PP
Department of Psychiatry and Behavioral Sciences, University of Washington Medical School, Seattle 98195.
Cowley
D S
DS
Hommer
D
D
Greenblatt
D J
DJ
Kramer
G L
GL
Petty
F
F
D000328:Adult; D000525:Alprazolam / Q000494:pharmacology / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000097:blood* / Q000188:drug therapy / Q000523:psychology; D003975:Diazepam / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D016584:Panic Disorder / Q000097:blood / Q000188:drug therapy / Q000523:psychology; D011569:Psychiatric Status Rating Scales; D005680:gamma-Aminobutyric Acid / Q000097:blood*
D014151:Anti-Anxiety Agents; D005680:gamma-Aminobutyric Acid; D003975:Diazepam; D000525:Alprazolam